Will Car T Cells Smash Tumors?

Meet some of the people featured in the April 2019 issue of The Scientist.

A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.

Take a break from the bench to puzzle and peruse.

Selected Images of the Day from the-scientist.com

At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.

A large study seeks to answer whether a man’s childhood diet has transgenerational repercussions.

The molecular processes that lead males to be more susceptible to the disease are only beginning to come to light.

A group of scientists in northern Norway are using the technique to measure biodiversity’s response to past and present climate change.

A prototype in-vein device would collect toxic medications before they reach healthy tissues.

Researchers disentangle how adipocytes communicate with prostate tumors in mice.

Researchers found that allegedly noncoding genetic material carries the instructions for many peptides that may help harness the immune system to fight cancer.

Similarities in gene expression hint at the origin of a certain type of pancreatic tumor that predominantly afflicts women.

The Mount Sinai oncologist studies innate immune cells with the goal of designing novel immunotherapies, including cancer vaccines.

The Michigan State University researcher’s lab experiences shaped her interest in the role of glucose in cancer’s spread.

Researchers describe ways to study how cancer cells evade therapies that harness the immune system.

Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.

This posthumously published collection of essays by Oliver Sacks further cements the neurologist’s place in the pantheon of science writers.

Mustard gas blistered men’s bodies on the battlefield, but paved the way for cancer-fighting drugs.

Tumor accessibility, heterogeneity, and microenvironment vary between the two classes of malignancies.

Only a handful of contagious cancers are known to exist, yet they have attracted an increasing number of researchers worldwide trying to understand how and why they arise.

Analyzing protein-protein interactions can shed light on what tiny proteins do in the cell.

Researchers have developed a prototype device to filter excess chemotherapy medication from the bloodstream.

Mice that lack p62 in their fat cells grow more tumors than animals that have a functioning version of the protein.